Acumen Pharmaceuticals In... (ABOS)
1.65
0.04 (2.48%)
At close: Jan 17, 2025, 3:59 PM
1.65
0.00%
After-hours Jan 17, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 66.89M | 130.10M | 122.16M | 43.78M | 6.55M |
| Short-Term Investments | 176.64M | 47.50M | 72.08M | n/a | n/a |
| Long-Term Investments | 62.55M | 15.84M | 31.62M | n/a | n/a |
| Other Long-Term Assets | 454.00K | 151.00K | 14.00K | n/a | 144.00K |
| Receivables | 225.00K | n/a | n/a | 109.00K | 30.00K |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.87M | 2.72M | 4.42M | 543.00K | 1.14M |
| Total Current Assets | 246.62M | 180.33M | 198.66M | 44.43M | 7.18M |
| Property-Plant & Equipment | 503.00K | 270.00K | 36.00K | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 63.51M | 16.26M | 31.67M | n/a | 144.00K |
| Total Assets | 310.13M | 196.59M | 230.33M | 44.43M | 7.32M |
| Account Payables | 1.38M | 1.64M | 1.09M | 531.00K | 223.00K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 1.73M | 210.00K | n/a | n/a | n/a |
| Other Current Liabilities | 9.86M | 5.96M | 4.06M | 5.84M | 1.12M |
| Total Current Liabilities | 12.97M | 7.81M | 5.15M | 6.37M | 1.34M |
| Long-Term Debt | 27.62M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 2.56M | n/a | n/a | 56.65M | 17.40M |
| Total Long-Term Liabilities | 30.18M | n/a | n/a | 56.65M | 17.40M |
| Total Liabilities | 43.15M | 7.81M | 5.15M | 63.02M | 18.74M |
| Total Debt | 28.49M | 105.00K | n/a | n/a | n/a |
| Common Stock | 6.00K | 4.00K | 4.00K | n/a | n/a |
| Retained Earnings | -222.80M | -170.43M | -127.57M | -26.96M | -19.64M |
| Comprehensive Income | 312.00K | -751.00K | -231.00K | n/a | n/a |
| Shareholders Equity | 266.97M | 188.78M | 225.18M | -18.59M | -11.42M |
| Total Investments | 239.19M | 63.34M | 103.69M | n/a | n/a |